22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative
22nd Century Group highlighted an ANSES scientific assessment validating nicotine reduction in combustible tobacco and naming the company's plant-science approach as the only commercially available production path for very-low-nicotine cigarettes. The report recommends a maximum nicotine limit across all combustible products in France, potentially at the EU level via revision of Directive 2014/40/EU; XXII says its non-GMO reduced-nicotine tobacco removes a key implementation barrier and is sourced at commercial scale.
Key figures
- Us states vln
- 23
- Mrtp designation
- December 2021
- Nicotine reduction
- 95% less nicotine than traditional tobacco
- French retail market
- €20 billion+ annual
- Fda vln authorization
- December 2019
- Anses report validated
- December 5, 2025
- Estimated legal market
- €8-13 billion retail over first 3-5 years
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.